The University of Chicago Header Logo

Connection

Elaine Worcester to Calcium Oxalate

Back to Details
This is a "connection" page, showing publications Elaine Worcester has written about Calcium Oxalate.
Elaine Worcester
Connection Strength
9.132
Calcium Oxalate
  1. Contrasting Response of Urine Stone Risk to Medical Treatment in Calcium Oxalate versus Calcium Phosphate Stone Formers. Kidney360. 2024 02 01; 5(2):228-236.
    View in: PubMed
    Score: 0.744
  2. Metabolomic profiles and pathogenesis of nephrolithiasis. Curr Opin Nephrol Hypertens. 2023 09 01; 32(5):490-495.
    View in: PubMed
    Score: 0.718
  3. Stone Morphology Distinguishes Two Pathways of Idiopathic Calcium Oxalate Stone Pathogenesis. J Endourol. 2022 05; 36(5):694-702.
    View in: PubMed
    Score: 0.660
  4. Sex Differences of Kidney Stone Urine Risk Factors after Roux-en-Y Gastric Bypass. Am J Nephrol. 2021; 52(2):173-176.
    View in: PubMed
    Score: 0.612
  5. Evidence for disordered acid-base handling in calcium stone-forming patients. Am J Physiol Renal Physiol. 2020 02 01; 318(2):F363-F374.
    View in: PubMed
    Score: 0.558
  6. Randall's plaque in stone formers originates in ascending thin limbs. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1236-F1242.
    View in: PubMed
    Score: 0.509
  7. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am J Physiol Renal Physiol. 2013 Dec 01; 305(11):F1574-84.
    View in: PubMed
    Score: 0.364
  8. Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2083-92.
    View in: PubMed
    Score: 0.313
  9. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken). 2008 Mar; 291(3):325-34.
    View in: PubMed
    Score: 0.247
  10. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol. 2008 Mar; 28(2):111-9.
    View in: PubMed
    Score: 0.247
  11. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken). 2007 Oct; 290(10):1315-23.
    View in: PubMed
    Score: 0.240
  12. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 2006 Apr; 69(8):1313-8.
    View in: PubMed
    Score: 0.216
  13. Validation of a Renal Papillary Grading System: Comparison of Patients Forming Calcium Oxalate and Apatite Stones. J Endourol. 2026 May; 40(5):600-606.
    View in: PubMed
    Score: 0.215
  14. Phenotyping of Idiopathic Calcium Oxalate Stone Formers Reveals Risk Factors for Papillary Lesions and Chronic Renal Function. J Endourol. 2026 Mar; 40(3):388-395.
    View in: PubMed
    Score: 0.214
  15. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 2005 Jul; 68(1):145-54.
    View in: PubMed
    Score: 0.206
  16. Two distinct phenotypes of calcium oxalate stone formers could imply different long-term risks for renal function. Urolithiasis. 2024 Sep 28; 52(1):133.
    View in: PubMed
    Score: 0.195
  17. Collagen fibrils and cell nuclei are entrapped within Randall's plaques but not in CaOx matrix overgrowth: A microscopic inquiry into Randall's plaque stone pathogenesis. Anat Rec (Hoboken). 2022 07; 305(7):1701-1711.
    View in: PubMed
    Score: 0.160
  18. Demineralization and sectioning of human kidney stones: A molecular investigation revealing the spatial heterogeneity of the stone matrix. Physiol Rep. 2021 01; 9(1):e14658.
    View in: PubMed
    Score: 0.150
  19. Multimodal imaging reveals a unique autofluorescence signature of Randall's plaque. Urolithiasis. 2021 Apr; 49(2):123-135.
    View in: PubMed
    Score: 0.148
  20. In Vivo Renal Tubule pH in Stone-Forming Human Kidneys. J Endourol. 2020 02; 34(2):203-208.
    View in: PubMed
    Score: 0.141
  21. Inhibitors of stone formation. Semin Nephrol. 1996 Sep; 16(5):474-86.
    View in: PubMed
    Score: 0.111
  22. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid. Scanning Microsc. 1996; 10(2):415-23; 423-4.
    View in: PubMed
    Score: 0.106
  23. Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease. J Urol. 2015 Nov; 194(5):1308-12.
    View in: PubMed
    Score: 0.102
  24. Osteopontin inhibits nucleation of calcium oxalate crystals. Ann N Y Acad Sci. 1995 Apr 21; 760:375-7.
    View in: PubMed
    Score: 0.101
  25. Urinary calcium oxalate crystal growth inhibitors. J Am Soc Nephrol. 1994 Nov; 5(5 Suppl 1):S46-53.
    View in: PubMed
    Score: 0.098
  26. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014 Apr; 297(4):731-48.
    View in: PubMed
    Score: 0.093
  27. The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin. Calcif Tissue Int. 1993 Oct; 53(4):242-8.
    View in: PubMed
    Score: 0.091
  28. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res. 1992 Sep; 7(9):1029-36.
    View in: PubMed
    Score: 0.084
  29. Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res. 2010 Dec; 38(6):439-52.
    View in: PubMed
    Score: 0.074
  30. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 02; 363(10):954-63.
    View in: PubMed
    Score: 0.074
  31. Three pathways for human kidney stone formation. Urol Res. 2010 Jun; 38(3):147-60.
    View in: PubMed
    Score: 0.072
  32. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 2009 Nov; 76(10):1081-8.
    View in: PubMed
    Score: 0.069
  33. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol. 2009 Oct; 297(4):F1017-23.
    View in: PubMed
    Score: 0.068
  34. In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int. 2010 Jan; 105(2):242-5.
    View in: PubMed
    Score: 0.068
  35. Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol. 1988 Dec; 255(6 Pt 2):F1197-205.
    View in: PubMed
    Score: 0.065
  36. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int. 2009 Apr; 103(7):966-71.
    View in: PubMed
    Score: 0.065
  37. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8.
    View in: PubMed
    Score: 0.064
  38. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6.
    View in: PubMed
    Score: 0.064
  39. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int. 2007 Dec; 72(12):1503-11.
    View in: PubMed
    Score: 0.060
  40. Glycoprotein calcium oxalate crystal growth inhibitor in urine. Miner Electrolyte Metab. 1987; 13(4):267-72.
    View in: PubMed
    Score: 0.057
  41. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection. Am J Physiol Renal Physiol. 2006 Nov; 291(5):F1061-9.
    View in: PubMed
    Score: 0.056
  42. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest. 1986 Jun; 77(6):1888-96.
    View in: PubMed
    Score: 0.055
  43. Endoscopic evidence of calculus attachment to Randall's plaque. J Urol. 2006 May; 175(5):1720-4; discussion 1724.
    View in: PubMed
    Score: 0.054
  44. Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones. Nephrol Dial Transplant. 2006 Mar; 21(3):701-6.
    View in: PubMed
    Score: 0.053
  45. Kidney stone disease. J Clin Invest. 2005 Oct; 115(10):2598-608.
    View in: PubMed
    Score: 0.052
  46. Insights on the pathology of kidney stone formation. Urol Res. 2005 Nov; 33(5):383-9.
    View in: PubMed
    Score: 0.052
  47. A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. Nat Commun. 2023 07 19; 14(1):4140.
    View in: PubMed
    Score: 0.045
  48. End Point Considerations for Clinical Trials in Enteric Hyperoxaluria. Clin J Am Soc Nephrol. 2023 12 01; 18(12):1637-1644.
    View in: PubMed
    Score: 0.045
  49. Stones from bowel disease. Endocrinol Metab Clin North Am. 2002 Dec; 31(4):979-99.
    View in: PubMed
    Score: 0.043
  50. Clinical Effectiveness of Calcium Oxalate Stone Treatments. Am J Nephrol. 2022; 53(10):761-766.
    View in: PubMed
    Score: 0.043
  51. What treatments reduce kidney stone risk in patients with bowel disease? Urolithiasis. 2022 Oct; 50(5):557-565.
    View in: PubMed
    Score: 0.042
  52. Role of anionic proteins in kidney stone formation: interaction between model anionic polypeptides and calcium oxalate crystals. J Urol. 2000 Apr; 163(4):1343-8.
    View in: PubMed
    Score: 0.036
  53. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int. 1998 Apr; 53(4):952-7.
    View in: PubMed
    Score: 0.031
  54. Osteopontin production by cultured kidney cells. Ann N Y Acad Sci. 1995 Apr 21; 760:266-78.
    View in: PubMed
    Score: 0.025
  55. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken). 2015 May; 298(5):865-77.
    View in: PubMed
    Score: 0.025
  56. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int. 2010 Aug; 78(3):310-7.
    View in: PubMed
    Score: 0.018
  57. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003 Jan; 63(1):255-65.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.